Showing results (31-40 of 71) with videos related to

Sort By:
Pageof 8
Molecular Cancer Therapeutics|July 12, 2019
A Novel Anti-HER2 Antibody-Drug Conjugate XMT-1522 for HER2-Positive Breast and Gastric Cancers Resistant to Trastuzumab EmtansineVadim Le Joncour, Ana Martins, Maija Puhka, et al.
Clinical & Experimental Metastasis|February 17, 2024
Comparison of trastuzumab emtansine, trastuzumab deruxtecan, and disitamab vedotin in a multiresistant HER2-positive breast cancer lung metastasis modelNegar Pourjamal, Narjes Yazdi, Aleksi Halme, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 16, 2004
Antitumor activity of a homing peptide that targets tumor lymphatics and tumor cellsPirjo Laakkonen, Maria E Akerman, Hector Biliran, et al.
Biological Chemistry|July 17, 2008
Development of peptides specifically modulating the activity of KLK2 and KLK3Hannu Koistinen, Ale Närvänen, Miikka Pakkala, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 11, 2017
Motility of glioblastoma cells is driven by netrin-1 induced gain of stemnessIrene Ylivinkka, Harri Sihto, Olli Tynninen, et al.
Bioconjugate Chemistry|January 29, 2013
Peptide-based glioma-targeted drug delivery vector gHoPe2Elo Eriste, Kaido Kurrikoff, Julia Suhorutšenko, et al.
International Journal of Molecular Sciences|March 10, 2022
Bivalent EGFR-Targeting DARPin-MMAE ConjugatesLennard Karsten, Nils Janson, Vadim Le Joncour, et al.
Neuroscience|June 14, 2026
Differential cytotoxic effect of polybrene on distinct glioblastoma subtypesZeynep Iloglu, Mengfan Li, Vasiliki Gkini, et al.
Pageof 8